IMW 2019, Boston
We are delighted to award 4 travel bursaries to the International Myeloma Workshop in Boston on 12-15th September 2019.
There were fortunate to receive high quality abstracts. Thank you to our judging panel who had the challenging task of awarding these travel bursaries. Congratulations to winners of the joint UKMF platinum sponsor Travel Bursary to IMW in Boston; Wei Yee Chan (UCL) – The Binding Site, Firas Al-Kaisi (Nottingham City Hospital) – Takeda, Roisin McAvera (Queen’s University Belfast) – Celgene and Sarah Bird (Royal Marsden) – Amgen.
Documents
- Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction chemotherapy in the PADIMAC study
- A short term biomarker based assay predicts apoptotic response to combined BCL-2/MCL-1 BH3 mimetic targeting in Myeloma cells
- Loss of TRIM33 in Multiple Myeloma correlates with increased genomic instability
- A ‘real-world’ study of panobinostat, bortezomib and dexamethasone in a very heavily pretreated population of myeloma patients